Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin

被引:60
作者
Ward, PB
Johnson, PDR
Grabsch, EA
Mayall, BC
Grayson, ML
机构
[1] Austin & Repatriat Med Ctr, Dept Microbiol, Heidelberg, Vic 3084, Australia
[2] Austin & Repatriat Med Ctr, Dept Infect Dis, Heidelberg, Vic 3084, Australia
关键词
D O I
10.5694/j.1326-5377.2001.tb143681.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report the first instance in Australia of treatment failure due to a strain of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin - heteroresistant vancomycin-intermediate S. aureus (hVISA). The infection occurred in a 41-year-old man with multiple risk factors. No transmission of the organism to other patients or the environment was detected. This case may herald the beginning of a new phase of staphylococcal resistance in Australia.
引用
收藏
页码:480 / +
页数:5
相关论文
共 24 条
  • [1] Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V48, P1165
  • [2] Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy
    Drew, RH
    Perfect, JR
    Srinath, L
    Kurkimilis, E
    Dowzicky, M
    Talbot, GH
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) : 775 - 784
  • [3] FEKETY R, 2000, PRINCIPLES PRACTICE, P382
  • [4] Fridkin SK, 2001, CLIN INFECT DIS, V32, P108, DOI 10.1086/317542
  • [5] Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf area
    Geisel, R
    Schmitz, FJ
    Thomas, L
    Berns, G
    Zetsche, O
    Ulrich, B
    Fluit, AC
    Labischinsky, H
    Witte, W
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (06) : 846 - 848
  • [6] The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995)
    Gottlieb, T
    Mitchell, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (01) : 67 - 73
  • [7] Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50
    Hanaki, H
    Kuwahara-Arai, K
    Boyle-Vavra, S
    Daum, RS
    Labischinski, H
    Hiramatsu, K
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) : 199 - 209
  • [8] Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
    Hiramatsu, K
    Aritaka, N
    Hanaki, H
    Kawasaki, S
    Hosoda, Y
    Hori, S
    Fukuchi, Y
    Kobayashi, I
    [J]. LANCET, 1997, 350 (9092) : 1670 - 1673
  • [9] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
    Hiramatsu, K
    Hanaki, H
    Ino, T
    Yabuta, K
    Oguri, T
    Tenover, FC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) : 135 - 136
  • [10] Hiramatsu Keiichi, 1998, American Journal of Medicine, V104, p7S, DOI 10.1016/S0002-9343(98)00149-1